These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32762938)

  • 1. How to manage rheumatic and musculoskeletal diseases - Preface.
    Stamm T; Moe RH
    Best Pract Res Clin Rheumatol; 2020 Apr; 34(2):101568. PubMed ID: 32762938
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas GD; Dimitroulas T
    Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Not Available].
    Burmester GR
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S2. PubMed ID: 26536183
    [No Abstract]   [Full Text] [Related]  

  • 4. A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical education : White paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD).
    Al Maini M; Al Weshahi Y; Foster HE; Chehade MJ; Gabriel SE; Saleh JA; Al Wahshi H; Bijlsma JWJ; Cutolo M; Lakhanpal S; Venkatramana M; Pineda C; Woolf AD
    Clin Rheumatol; 2020 Mar; 39(3):627-642. PubMed ID: 31127461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatology, a clinical overview.
    Whisler RL; Gray LS; Hackshaw KV
    Clin Podiatr Med Surg; 2002 Jan; 19(1):149-61, vii. PubMed ID: 11806162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Strangfeld A
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S3-4. PubMed ID: 26536188
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V;
    Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328
    [No Abstract]   [Full Text] [Related]  

  • 8. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
    Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
    Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatic rarities. Preface.
    Kay J
    Rheum Dis Clin North Am; 2013 May; 39(2):xv-xvi. PubMed ID: 23597977
    [No Abstract]   [Full Text] [Related]  

  • 10. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.
    Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK
    Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum clinically important difference: the crock of gold at the end of the rainbow?
    Kirwan JR
    J Rheumatol; 2001 Feb; 28(2):439-44. PubMed ID: 11246693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing rheumatic and musculoskeletal diseases - past, present and future.
    Burmester GR; Bijlsma JWJ; Cutolo M; McInnes IB
    Nat Rev Rheumatol; 2017 Jul; 13(7):443-448. PubMed ID: 28615732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of management of musculoskeletal conditions in children and young people.
    Davis PJ; McDonagh JE
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):263-78. PubMed ID: 16546056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell therapies : New options in the treatment of rheumatic and musculoskeletal diseases].
    Alexander T; Burmester G
    Z Rheumatol; 2020 Jun; 79(5):417-418. PubMed ID: 32494983
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Single-Blind Parallel-Arm Randomized Controlled Trial.
    Keysor JJ; LaValley MP; Brown C; Felson DT; AlHeresh RA; Vaughan MW; Yood R; Reed JI; Allaire SJ
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1022-1029. PubMed ID: 28941189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health planning in rheumatic diseases. Elaboration of a master plan for rheumatic and musculoskeletal diseases of Catalonia.
    Larrosa M; Surís X; Pueyo MJ; Auleda J; de la Puente ML
    Reumatol Clin; 2012; 8(2):72-7. PubMed ID: 22341527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal clinically important difference module: summary, recommendations, and research agenda.
    Wells G; Anderson J; Beaton D; Bellamy N; Boers M; Bombardier C; Breedveld F; Carr A; Cranney A; Dougados M; Felson D; Kirwan J; Schiff M; Shea B; Simon L; Smolen J; Strand V; Tugwell P; van Riel P; Welch VA
    J Rheumatol; 2001 Feb; 28(2):452-4. PubMed ID: 11246695
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on sarcopenia in patients with rheumatic musculoskeletal diseases.
    Teng CT; Chen YJ; Tsai YF; Yong SB; Wei JC
    Int J Rheum Dis; 2024 Sep; 27(9):e15332. PubMed ID: 39278725
    [No Abstract]   [Full Text] [Related]  

  • 19. General Practitioners and Rheumatologists: new bridges for a successful cooperation.
    Pereira da Silva JA; Cernadas R; Canas da Silva J
    Acta Reumatol Port; 2017; 42(1):6-7. PubMed ID: 28371570
    [No Abstract]   [Full Text] [Related]  

  • 20. Providing Rheum with a View.
    Mandell BF
    Med Clin North Am; 2021 Mar; 105(2):xv-xvi. PubMed ID: 33589112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.